🦊/Companies

Stemmatters

1 known investors

Find your way into Stemmatters

518 people in our graph share verified history with the Stemmatters team — schools, employers, funds. One of them is your warm intro.

Sumit Joharunlockedknows Vitor Dinis · together at Wipro Limited (overlapped)
×7knows the team · via Arthur Andersen & Co.
×3knows the team · via Brunel University of London
knows the team · via Wipro Limited

Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.

Founders & leadership

RARui A. Sousa
Rui A. SousainCEORui A. Sousa is CEO of Stemmatters, a Contract Development and Manufacturing Organisation specializing in regenerative medicine and advanced therapy medicinal products. He has led the company's research and development operations, regulatory strategy, and establishment of business partnerships in the life sciences sector.
VDVitor Dinis
Vitor DinisinBoard Member & CFOVitor Dinis is a co-founder and CFO of Pathena, a venture capital firm, where he serves as a Non-Executive Board Member of portfolio companies. He holds a Master's degree in Accounting and Business Management from Oporto Accounting Institute and has held senior finance and audit roles at Arthur Andersen, Deloitte, Enabler (where he served as CFO), and Wipro Technologies.

Investors · 1

Competitors · 4

by search overlap
bio6 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
PAREXEL4 shared keywordsParexel is a contract research organization (CRO) providing clinical development, regulatory consulting, and market access services for biopharmaceutical companies conducting clinical trials across phases I-IV globally. The company operates with a network of offices and specialized facilities across North America, Latin America, Europe, and Asia-Pacific.
Fraunhofer IAO4 shared keywordsFraunhofer is a research organization whose Institute for Toxicology and Experimental Medicine (ITEM) conducts contract research, including cell-based in vitro inhalation methods to assess respiratory effects of aerosols and identify potentially harmful substances without animal testing. Its work supports safe product development under a safe-by-design approach.
Microbiotica4 shared keywordsMicrobiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.

Companies competing with Stemmatters for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Stemmatters do?
Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.
Who are Stemmatters's investors?
Stemmatters's investors include Beta Capital.